1 day Green stocks on red days Reddit

   X     

4 days AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant Seeking Alpha

   X     

4 days AbbVie Appears Ready To Move Higher Seeking Alpha

   X     

1 week AbbVie: An Undervalued Dividend Aristocrat Seeking Alpha

   X     

1 week AbbVie Just Paid Investors: Here’s How Much They Received 24/7 Wall St.

   X     

2 weeks The Zacks Analyst Blog Walmart, Visa, AbbVie and AstroNova Zacks

   X     

2 weeks Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie Zacks

   X     

3 weeks AbbVie Rises 8% Since Q4 Earnings: Buy, Hold or Sell the Stock? Zacks

   X     

3 weeks Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers. Yahoo Finance

   X     

3 weeks Company News for Feb 3, 2025 Zacks

   X     

3 weeks Market Digest: SNY, BX, CLS, FL, GE, MSFT, NFG, SHEL, SYK, WBA, WM, WY, ABBV, BKR Yahoo Finance

   X     

3 weeks AbbVie Q4 Earnings: Strong Revenue Results, Ambitious Forecasts – A Buy With Caveats Seeking Alpha

   X     

3 weeks AbbVie Q4 Earnings: Good 2025 Outlook Despite Enhanced Old And New Headwinds Seeking Alpha

   X     

3 weeks AbbVie, Avago Lead Market Cap Stock Movers on Friday Investing.com

   X     

3 weeks AbbVie Stock Soars on Key Drugs’ Sales Forecasts Yahoo Finance

   X     

3 weeks AbbVie Beats on Q4 Earnings & Sales, Raises Sales View for Key Drugs Zacks

   X     

3 weeks AbbVie Inc. (ABBV) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

3 weeks These Stocks Moved the Most Today: Apple, Intel, Chevron, Exxon, Walgreens, AbbVie, Deckers, Atlassian, Vertex, and More Yahoo Finance

   X     

3 weeks AbbVie Stock Jumps on Earnings and Revenue Beat Yahoo Finance

   X     

3 weeks Compared to Estimates, AbbVie (ABBV) Q4 Earnings: A Look at Key Metrics Zacks

   X     

3 weeks AbbVie Surges 5% As Immunology Powerhouses Skyrizi And Rinvoq Continue To Dominate Investor's Business Daily

   X     

3 weeks AbbVie (ABBV) Q4 Earnings and Revenues Surpass Estimates Zacks

   X     

3 weeks AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs Investing.com

   X     

3 weeks AbbVie forecasts 2025 profit above estimates on newer immunology drugs Yahoo Finance

   X     

3 weeks AbbVie earnings beat by $0.10, revenue topped estimates Investing.com

   X     

3 weeks AbbVie, Exxon, Chevron, and more to report earnings Friday Investing.com

   X     

4 weeks Do Options Traders Know Something About AbbVie (ABBV) Stock We Don’t? Zacks

   X     

4 weeks AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine Seeking Alpha

   X     

4 weeks AbbVie (ABBV) Stock Moves -0.22%: What You Should Know Zacks

   X     

4 weeks Earnings Preview: AbbVie (ABBV) Q4 Earnings Expected to Decline Zacks

   X     

4 weeks AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders Zacks

   X     

1 month Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here’s Why Investor's Business Daily

   X     

1 month Why the Market Dipped But AbbVie (ABBV) Gained Today Zacks

   X     

1 month The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio Zacks

   X     

1 month Regenxbio: Wet AMD ABBV-RGX-314 Results Remain On Track For 2026 Seeking Alpha

   X     

1 month Top Research Reports for Visa, AbbVie & Analog Devices Zacks

   X     

1 month AbbVie Inc. (ABBV) J.P. Morgan 43rd Annual Healthcare Conference (Transcript) Seeking Alpha

   X     

1 month AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock? Zacks

   X     

1 month AbbVie Has Immense Cash Flow Potential Seeking Alpha

   X     

1 month AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug Yahoo Finance

   X     

1 month AbbVie’s Stock Is Unfairly Cheap Seeking Alpha

   X     

2 months Opinion on my current portfolio Reddit

   X     

2 months AbbVie (ABBV) Stock Moves -0.32%: What You Should Know Zacks

   X     

2 months Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

2 months AbbVie cuts 2024 profit forecast on acquisition expenses Investing.com

   X     

2 months The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

2 months AbbVie (ABBV) Gains As Market Dips: What You Should Know Zacks

   X     

2 months Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet Zacks

   X     

2 months AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

2 months AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

   X